Hudson People
Michael Gantier

Dr Michael Gantier, Research Group Head, Nucleic Acids and Innate Immunity Research group

Working on treatment for COVID-19, repurposing existing cancer drug

WORK-LIFE | The next round of grant applications is critical for my lab. Our funding ends in December. The pandemic has changed the grant evaluation process, meaning funding outcomes will be even more uncertain. On the other hand, the situation has created novel grant and commercial opportunities, which may help my team stay afloat. Any further funding for my laboratory at this very stressful time could be the difference between our vital COVID-19 research continuing, or ceasing.­

This is the first time in ages that science is at the top of news bulletins, every day. The only way out of this pandemic is biomedical research.

HOME-LIFE | Working at home with my three-and-a-half-year-old son and seven-year-old daughter has been challenging. Homeschooling my daughter has taken its toll on my productivity writing grants and publications, as my partner is also working full-time from home. We make it work, but I am not sure there is any balance! I gave in on two things this year – a trampoline and a puppy!